# Source:Washington Examiner - politics, URL:https://feeds.feedburner.com/dcexaminer/Politics, language:en-US

## FDA to fast-track review of application to allow NARCAN to be sold over the counter
 - [https://www.washingtonexaminer.com/news/fda-to-fast-track-review-of-application-to-allow-narcan-to-be-sold-over-the-counter](https://www.washingtonexaminer.com/news/fda-to-fast-track-review-of-application-to-allow-narcan-to-be-sold-over-the-counter)
 - RSS feed: https://feeds.feedburner.com/dcexaminer/Politics
 - date published: 2022-12-07 13:29:36+00:00

(The Center Square) – The U.S. Food and Drug Administration accepted Emergent BioSolutions' request to review its supplemental New Drug Application for the NARCAN® Nasal Spray to be sold as an over-the-counter emergency treatment for known or suspected opioid overdose, the company said Tuesday.

## Vape maker Juul to pay Indiana $15.7M over alleged deceptive marketing to minors
 - [https://www.washingtonexaminer.com/news/vape-maker-juul-to-pay-indiana-15-7m](https://www.washingtonexaminer.com/news/vape-maker-juul-to-pay-indiana-15-7m)
 - RSS feed: https://feeds.feedburner.com/dcexaminer/Politics
 - date published: 2022-12-07 13:26:46+00:00

(The Center Square) — Indiana will receive payment of $15.7 million from e-cigarette maker Juul Labs Inc. to settle allegations Juul engaged in deceptive marketing practices targeting minors. It has been unlawful to sell tobacco products, including e-cigarettes, to persons under the age of 21 in the United States since 2019.

